IMED Biotech Unit
With the transformation we have made in the IMED Biotech Unit over the past seven years, we are now in the best possible position to enable the translation of innovative science into life-changing medicines. Improving our success rates from pre-clinical development to Phase III completion – from 4% to 19% – is the result of establishing an open, collaborative and truth-seeking culture of leading scientists, leading science.Mene Pangalos, FRSB, FMedSci, EVP IMED Biotech Unit and Global Business Development
Our scientific advances are the result of our scientific rigour
As AstraZeneca’s research and early development biotech unit, our IMED team is turning science fiction into science fact, fuelling a pipeline of new molecules from early disease understanding and initial target selection to Phase II trial completion.
Truth-seeking curiosity and scientific rigour
Our scientific advances are the result of our scientific rigour – our unique 5R Framework: right target, right tissue, right safety, right patient, right commercial, ensures we put science first in everything we do.
Key skills and capabilities
Our ground-breaking research agenda brings together the brightest minds. We harness a unique mix of scientific skills and capabilities, bringing together people from diverse backgrounds and a rich variety of expertise.
We pursue scientific breakthroughs to redefine medicine
Our leading scientists are redefining medical science in the quest for new and better ways to discover, test and accelerate novel drug candidates and to realise the potential of precision medicine to transform disease. We are determined to advance our understanding of disease biology to uncover novel drivers for the diseases we aim to treat, prevent and even cure.
As part of our effort to make every target druggable, we are diversifying our drug platforms to develop new therapies against an array of drug target classes. Around 30% of our programmes now explore new modalities and drug delivery devices.
We empower our people to make bold decisions
Every day, we empower our people to make bold decisions and ask big questions in pursuit of the breakthroughs that could change patients’ lives.
We open doors to fuel scientific discovery
Through our network of world-class scientists, we work collaboratively and open doors to fuel scientific discovery, deepening our understanding of disease and discovering the effects of novel drug candidates on individuals, so that in the future our medicines could be tailored to the specific needs of each person who needs them.